| Regulatory Rapporteur December 2020 | MEMBERS |
| Medical Devices / IVDs Symposium: Post-market surveillance | MEMBERS |
| TOPRA Symposium: Symposium in pictures | MEMBERS |
| Medical Devices / IVDs Symposium: Preparing for the IVDR | MEMBERS |
| TOPRA Symposium: Innovation and regulation in the interface of medicines, medical devices and companion diagnostics | MEMBERS |
| Human Medicines Symposium: Regulatory support to research and development | MEMBERS |
| Human Medicines Symposium: Driving the healthcare regulatory system into the future | MEMBERS |
| Human Medicines Symposium: Innovation in clinical trials | MEMBERS |
| Medical Devices / IVDs Symposium: Software as a medical device | MEMBERS |
| Human Medicines Symposium: What can we learn for prospective evidence planning? | MEMBERS |
| Medical Devices / IVDs Symposium: Clinical evidence: an evident challenge | MEMBERS |
| Veterinary Medicines Symposium: Challenges of responding to new disease outbreaks | MEMBERS |
| Veterinary Medicines Regulation: Opportunities of global regulatory convergence | MEMBERS |
| TOPRA Symposium: Combination Products - How to regulate and innovate | MEMBERS |
| Veterinary Medicines Symposium: Regulation versus innovation | MEMBERS |
| Human Medicines Symposium: The expansion of regulatory innovation in other markets | MEMBERS |
| Veterinary Medicines Symposium: Practical implementation of the new vet regulation | MEMBERS |
| Veterinary Medicines Symposium: Parallel strategic developments in the EU regulatory network | MEMBERS |
| Medical Devices / IVDs Symposium: General update on MDR and IVDR | MEMBERS |
| Human Medicines Symposium: Orphan and paediatric policy updates | MEMBERS |